{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T03:51:08Z","timestamp":1782964268578,"version":"3.54.5"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T00:00:00Z","timestamp":1721433600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biochem Biophys"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s12013-024-01435-1","type":"journal-article","created":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T16:08:31Z","timestamp":1721491711000},"page":"3489-3498","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms of Rehmannioside A Against Systemic Lupus Erythematosus Based on Network Pharmacology, Molecular Docking and Molecular Dynamics Simulation"],"prefix":"10.1007","volume":"82","author":[{"given":"Guofei","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Xin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,20]]},"reference":[{"key":"1435_CR1","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","volume":"56","author":"F Rees","year":"2017","unstructured":"Rees, F., Doherty, M., & Grainge, M. J., et al. (2017). The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatology (Oxford), 56, 1945\u20131961. https:\/\/doi.org\/10.1093\/rheumatology\/kex260","journal-title":"Rheumatology (Oxford)"},{"key":"1435_CR2","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1136\/ard-2022-223741","volume":"82","author":"MK Crow","year":"2023","unstructured":"Crow, M. K.(2023). Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets. Annals of the Rheumatic Diseases, 82, 999\u20131014.https:\/\/doi.org\/10.1136\/ard-2022-223741","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"1","key":"1435_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1136\/ard-2023-224762","volume":"83","author":"A Fanouriakis","year":"2024","unstructured":"Fanouriakis, A., Kostopoulou, M. & Andersen, J. et al. (2024). EULAR recommendations for the management of systemic lupus erythematosus: 2023 update. Annals of the Rheumatic Diseases, 83(1), 15\u201329. https:\/\/doi.org\/10.1136\/ard-2023-224762","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1435_CR4","doi-asserted-by":"publisher","first-page":"v29","DOI":"10.1093\/rheumatology\/keaa382","volume":"59","author":"L Arnaud","year":"2020","unstructured":"Arnaud, L., & Tektonidou, M. G. (2020). Long-term outcomes in systemic lupus erythematosus: trends over time and major contributors. Rheumatology (Oxford), 59, v29\u2013v38. https:\/\/doi.org\/10.1093\/rheumatology\/keaa382","journal-title":"Rheumatology (Oxford)"},{"key":"1435_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109492","volume":"120","author":"M Sun","year":"2019","unstructured":"Sun, M., Shen, X. & Ma, Y. (2019). Rehmannioside A attenuates cognitive deficits in rats with vascular dementia (VD) through suppressing oxidative stress, inflammation and apoptosis. Biomedical and Pharmacology Journal, 120, 109492.https:\/\/doi.org\/10.1016\/j.biopha.2019.109492 20191005.","journal-title":"Biomedical and Pharmacology Journal"},{"key":"1435_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115021","volume":"289","author":"C Fu","year":"2022","unstructured":"Fu, C., Wu, Y. & Liu, S. et al. (2022). Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K\/AKT\/Nrf2 and SLC7A11\/GPX4 signaling pathway after ischemia. Journal of Ethnopharmacology, 289, 115021. https:\/\/doi.org\/10.1016\/j.jep.2022.115021 20220126.","journal-title":"Journal of Ethnopharmacology"},{"key":"1435_CR7","doi-asserted-by":"publisher","first-page":"20231204","DOI":"10.1080\/07391102.2023.2289038","volume":"1-15","author":"X Guo","year":"2023","unstructured":"Guo, X., Wang, F. & Zheng, M. et al. (2023). Network pharmacology and molecular docking to study the potential molecular mechanism of Qi Fu Yin for diabetic encephalopathy. Journal of Biomolecular Structure and Dynamics, 1-15, 20231204.https:\/\/doi.org\/10.1080\/07391102.2023.2289038.","journal-title":"Journal of Biomolecular Structure and Dynamics"},{"key":"1435_CR8","doi-asserted-by":"publisher","first-page":"W26-31.","DOI":"10.1093\/nar\/gku477","volume":"42","author":"J Nickel","year":"2014","unstructured":"Nickel, J., Gohlke, B. O. & Erehman, J. et al. (2014). SuperPred: update on drug classification359 and target prediction. Nucleic. Nucleic Acids Research, 42, W26-31.\u2013W31. https:\/\/doi.org\/10.1093\/nar\/gku477.","journal-title":"Nucleic Acids Research"},{"key":"1435_CR9","doi-asserted-by":"publisher","first-page":"D877","DOI":"10.1093\/nar\/gkw1012","volume":"45","author":"N Rappaport","year":"2017","unstructured":"Rappaport, N., Twik, M., & Plaschkes, I., et al. (2017). MalaCards: an amalgamated human disease compendium with diverse clinical and genetic annotation and structured search. Nucleic Acids Research, 45, D877\u2013D887. https:\/\/doi.org\/10.1093\/nar\/gkw1012. 20161128.","journal-title":"Nucleic Acids Research"},{"key":"1435_CR10","doi-asserted-by":"publisher","first-page":"D845","DOI":"10.1093\/nar\/gkz1021","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J., Ramirez-Anguita, J. M., & Sauch-Pitarch, J., et al. (2020). The DisGeNET knowledge platform for disease genomics: 2019 update. Nucleic Acids Research, 48, D845\u2013D855. https:\/\/doi.org\/10.1093\/nar\/gkz1021.","journal-title":"Nucleic Acids Research"},{"key":"1435_CR11","doi-asserted-by":"publisher","first-page":"D605","DOI":"10.1093\/nar\/gkaa1074","volume":"49","author":"D Szklarczyk","year":"2021","unstructured":"Szklarczyk, D., Gable, A. L., & Nastou, K. C. et al.(2021). The STRING database in 2021: customizable protein-proteinnetworks, and functional characterization of user-uploaded gene\/measurement sets. Nucleic Acids Research, 49, D605\u2013D612. https:\/\/doi.org\/10.1093\/nar\/gkaa1074.","journal-title":"Nucleic Acids Research"},{"key":"1435_CR12","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L. G. & Han, Y. et al. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS, 16, 284\u2013287. https:\/\/doi.org\/10.1089\/omi.2011.0118.","journal-title":"OMICS"},{"key":"1435_CR13","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1002\/art.10541","volume":"46","author":"MJ Leandro","year":"2002","unstructured":"Leandro, M. J., Edwards, J. C. & Cambridge, G. et al. (2002). An open study of B lymphocyte depletion in systemic lupus erythematosus. Arthritis and Rheumatology, 46, 2673\u20132677. https:\/\/doi.org\/10.1002\/art.10541.","journal-title":"Arthritis and Rheumatology"},{"key":"1435_CR14","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1002\/acr.22173","volume":"66","author":"M Yurkovich","year":"2014","unstructured":"Yurkovich, M., Vostretsova, K. & Chen, W. et al.(2014). Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care and Research, 66, 608\u2013616. https:\/\/doi.org\/10.1002\/acr.22173.","journal-title":"Arthritis Care and Research"},{"key":"1435_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.semarthrit.2015.09.006","volume":"45","author":"YC Ma","year":"2016","unstructured":"Ma, Y. C., Lin, C. C. & Li, C. I. et al. (2016). Traditional Chinese medicine therapy improves the survival of systemic lupus erythematosus patients. Seminars in Arthritis and Rheumatism, 45, 596\u2013603. https:\/\/doi.org\/10.1016\/j.semarthrit.2015.09.006.","journal-title":"Seminars in Arthritis and Rheumatism"},{"key":"1435_CR16","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1007\/s11596-006-0609-1","volume":"26","author":"S Hu","year":"2006","unstructured":"Hu, S., Xu, Q. & Xiao, W. et al. (2006). The expression of molecular chaperone HSP90 and IL-6 in patients with systemic lupus erythematosus. Journal of Huazhong University of Science and Technology - Medical Science, 26, 664\u2013666. https:\/\/doi.org\/10.1007\/s11596-006-0609-1.","journal-title":"Journal of Huazhong University of Science and Technology - Medical Science"},{"key":"1435_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/cmi.2012.5","volume":"9","author":"SK Shimp","year":"2012","unstructured":"Shimp, S. K., Chafin, C. B. & Regna, N. L. et al. (2012). Heat shock protein 90 inhibition by 17-DMAG lessens disease in the MRL\/lpr mouse model of systemic lupus erythematosus. Cellular and Molecular Immunology, 9, 255\u2013266.https:\/\/doi.org\/10.1038\/cmi.2012.5. 20120430.","journal-title":"Cellular and Molecular Immunology"},{"key":"1435_CR18","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1186\/s40064-016-1911-4","volume":"5","author":"YF Zou","year":"2016","unstructured":"Zou, Y. F., Xu, J. H. & Gu, Y. Y. et al. (2016). Single nucleotide polymorphisms of HSP90AA1 gene influence response of SLE patients to glucocorticoids treatment.Springerplus, 5, 222.https:\/\/doi.org\/10.1186\/s40064-016-1911-4.","journal-title":"Springerplus"},{"issue":"22","key":"1435_CR19","doi-asserted-by":"publisher","first-page":"7047","DOI":"10.1016\/j.bmc.2013.09.018","volume":"21","author":"MG Brasca","year":"2013","unstructured":"Brasca, M. G., Mantegani, S. & Amboldi, N. et al.(2013). Discovery of NMS-E973 as novel, selective and potent inhibitor of heat shock protein 90 (Hsp90). Bioorganic & Medicinal Chemistry, 21(22), 7047\u20137063. https:\/\/doi.org\/10.1016\/j.bmc.2013.09.018.","journal-title":"Bioorganic & Medicinal Chemistry"},{"issue":"18","key":"1435_CR20","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1016\/j.bmcl.2019.08.004","volume":"29","author":"X Fradera","year":"2019","unstructured":"Fradera, X., Methot, J. L. & Achab, A. et al. (2019). Design of selective PI3K\u03b4 inhibitors using an iterative scaffold-hopping workflow. Bioorganic and Medicinal Chemistry Letters, 29(18), 2575\u20132580. https:\/\/doi.org\/10.1016\/j.bmcl.2019.08.004.","journal-title":"Bioorganic and Medicinal Chemistry Letters"},{"key":"1435_CR21","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang, E. V., Barbi, J., & Yang, H. Y., et al. (2011). Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell, 146, 772\u2013784. https:\/\/doi.org\/10.1016\/j.cell.2011.07.033. 20110825.","journal-title":"Cell"},{"key":"1435_CR22","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s00251-013-0743-4","volume":"66","author":"CC Feng","year":"2014","unstructured":"Feng, C. C., Ye, Q. L., & Zhu, Y., et al. (2014). Lack of association between the polymorphisms of hypoxia-inducible factor 1A (HIF1A) gene and SLE susceptibility in a Chinese population. Immunogenetics, 66, 9\u201313. https:\/\/doi.org\/10.1007\/s00251-013-0743-4.","journal-title":"Immunogenetics"},{"issue":"3","key":"1435_CR23","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1074\/jbc.C200644200","volume":"278","author":"JM Elkins","year":"2003","unstructured":"Elkins, J. M., Hewitson, K. S. & McNeill, L. A. et al. (2003). Structure of factor-inhibiting hypoxia-inducible factor (HIF) reveals mechanism of oxidative modification of HIF-1 alpha. Journal of Biological Chemistry, 278(3), 1802\u20131806. https:\/\/doi.org\/10.1074\/jbc.C200644200.","journal-title":"Journal of Biological Chemistry"},{"key":"1435_CR24","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3899\/jrheum.180507","volume":"45","author":"DYH Yap","year":"2018","unstructured":"Yap, D. Y. H., Tang, C. & Chan, G. C. W. et al. (2018). Longterm Data on Sirolimus Treatment in Patients with Lupus Nephritis.The Journal of Rheumatology, 45, 1663\u20131670. https:\/\/doi.org\/10.3899\/jrheum.180507.","journal-title":"The Journal of Rheumatology"},{"key":"1435_CR25","doi-asserted-by":"publisher","first-page":"2236","DOI":"10.4049\/jimmunol.1301005","volume":"191","author":"ZW Lai","year":"2013","unstructured":"Lai, Z. W., Borsuk, R. & Shadakshari, A. et al. (2013). Mechanistic target of rapamycin activation triggers IL-4 production and necrotic death of double-negative T cells in patients with systemic lupus erythematosus. Journal of Immunology, 191, 2236\u20132246. https:\/\/doi.org\/10.4049\/jimmunol.1301005.","journal-title":"Journal of Immunology"},{"key":"1435_CR26","doi-asserted-by":"publisher","first-page":"4134","DOI":"10.4049\/jimmunol.1301859","volume":"192","author":"H Kato","year":"2014","unstructured":"Kato, H., & Perl, A. (2014). Mechanistic target of rapamycin complex 1 expands Th17 and IL-4+ CD4-CD8- double-negative T cells and contracts regulatory T cells in systemic lupus erythematosus.Journal of Immunology, 192, 4134\u20134144. https:\/\/doi.org\/10.4049\/jimmunol.1301859.","journal-title":"Journal of Immunology"},{"key":"1435_CR27","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1038\/nature06730","volume":"452","author":"R Colina","year":"2008","unstructured":"Colina, R., Costa-Mattioli, M., & Dowling, R. J. et al.(2008). Translational control of the innate immune response through IRF-7. Nature, 452, 323\u2013328. https:\/\/doi.org\/10.1038\/nature06730.","journal-title":"Nature"},{"key":"1435_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/jcp.25913","volume":"233","author":"Q Zeng","year":"2018","unstructured":"Zeng, Q., Qin, S. & Zhang, H. et al. (2018). Rapamycin attenuates BAFF-extended proliferation and survival via disruption of mTORC1\/2 signaling in normal and neoplastic B-lymphoid cells. Journal of Cellular Physiology, 233, 516\u2013529.https:\/\/doi.org\/10.1002\/jcp.25913. 20170503.","journal-title":"Journal of Cellular Physiology"},{"issue":"7","key":"1435_CR29","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1128\/MCB.00678-12","volume":"33","author":"AM M\u00e4rz","year":"2013","unstructured":"M\u00e4rz, A. M., Fabian, A. K., Kozany, C., Bracher, A., & Hausch, F. (2013). Large FK506-binding proteins shape the pharmacology of rapamycin. Molecular and Cellular Biology, 33(7), 1357\u20131367. https:\/\/doi.org\/10.1128\/MCB.00678-12.","journal-title":"Molecular and Cellular Biology"},{"key":"1435_CR30","doi-asserted-by":"publisher","unstructured":"Lartigue, A., Colliou, N. & Calbo, S. et al. Critical role of TLR2 and TLR4 in autoantibody production and glomerulonephritis in lpr mutation-induced mouse lupus. Journal of Immunology, 183, 6207\u20136216. https:\/\/doi.org\/10.4049\/jimmunol.0803219.","DOI":"10.4049\/jimmunol.0803219"},{"key":"1435_CR31","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","volume":"77","author":"K Ma","year":"2018","unstructured":"Ma, K., Li, J., & Wang, X. et al. (2018). TLR4(+)CXCR4(+) plasma cells drive nephritis development in systemic lupus erythematosus. Annals of the Rheumatic Diseases, 77, 1498\u20131506. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213615. 20180620.","journal-title":"Annals of the Rheumatic Diseases"},{"issue":"7242","key":"1435_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1038\/nature07830","volume":"458","author":"BS Park","year":"2009","unstructured":"Park, B. S., Song, D. H., Kim, H. M., Choi, B. S., Lee, H., & Lee, J. O. (2009). The structural basis of lipopolysaccharide recognition by the TLR4-MD-2 complex. Nature, 458(7242), 1191\u20131195. https:\/\/doi.org\/10.1038\/nature07830.","journal-title":"Nature"},{"key":"1435_CR33","doi-asserted-by":"publisher","unstructured":"Kshirsagar, S., Riedl, M. & Billing, H. et al. (2014). Akt-dependent enhanced migratory capacity of Th17cells from children with lupus nephritis. Journal of Immunology, 193 48953\u20134903. https:\/\/doi.org\/10.4049\/jimmunol.1400044.","DOI":"10.4049\/jimmunol.1400044"},{"key":"1435_CR34","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrrheum.2015.172","volume":"12","author":"A Perl","year":"2016","unstructured":"Perl, A. (2016). Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases. Nature Reviews Rheumatology, 12, 169\u2013182. https:\/\/doi.org\/10.1038\/nrrheum.2015.172. 20151224.","journal-title":"Nature Reviews Rheumatology"},{"key":"1435_CR35","doi-asserted-by":"publisher","unstructured":"Barber, D. F., Bartolome, A. & Hernandez, C. et al. PI3Kgamma inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus. Nature Medicine, 11, 933\u2013935. https:\/\/doi.org\/10.1038\/nm1291.","DOI":"10.1038\/nm1291"},{"key":"1435_CR36","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1172\/JCI30398","volume":"117","author":"T Wu","year":"2007","unstructured":"Wu, T., Qin, X., & Kurepa, Z. et al.(2007). Shared signaling networks active in B cells isolated from genetically distinct mouse models of lupus. Journal of Clinical Investigation, 117, 2186\u20132196. https:\/\/doi.org\/10.1172\/JCI30398.","journal-title":"Journal of Clinical Investigation"},{"key":"1435_CR37","doi-asserted-by":"publisher","first-page":"4867-","DOI":"10.3389\/fimmu.2022.949217","volume":"72","author":"Q Zeng","year":"2015","unstructured":"Zeng, Q., Zhang, H., & Qin, J. et al. (2015). Rapamycin inhibits BAFF-stimulated cell proliferation and survival by suppressing mTOR-mediated PP2A-Erk1\/2 signaling pathway in normal and neoplastic B-lymphoid cells.Cellular and Molecular Life Science, 72, 4867-\u20134884. https:\/\/doi.org\/10.3389\/fimmu.2022.949217.","journal-title":"Cellular and Molecular Life Science"},{"key":"1435_CR38","doi-asserted-by":"publisher","first-page":"949217.","DOI":"10.3389\/fimmu.2022.949217","volume":"13","author":"CL Zhu","year":"2022","unstructured":"Zhu, C. L., Xie, J., & Zhao, Z. Z. et al.(2022). PD-L1 maintains neutrophil extracellular traps release by inhibiting neutrophil autophagy in endotoxin-induced lung injury. Frontiers in Immunology, 13, 949217. https:\/\/doi.org\/10.3389\/fimmu.2022.949217.","journal-title":"Frontiers in Immunology"},{"key":"1435_CR39","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A., Furnrohr, B. G., & Amann, K. et al. (2010). Impairment of neutrophil extracellular trapdegradation is associated with lupus nephritis. Proceedings of the National Academy of Sciences of the United States of America, 107, 9813\u20139818. https:\/\/doi.org\/10.1073\/pnas.0909927107.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Cell Biochemistry and Biophysics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12013-024-01435-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12013-024-01435-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T12:08:52Z","timestamp":1732018132000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12013-024-01435-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,20]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1435"],"URL":"https:\/\/doi.org\/10.1007\/s12013-024-01435-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4502204\/v1","asserted-by":"object"}]},"ISSN":["1085-9195","1559-0283"],"issn-type":[{"value":"1085-9195","type":"print"},{"value":"1559-0283","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,20]]},"assertion":[{"value":"11 July 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}